Å·ÃÀAV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Vaccines and Immunotherapies Online Symposium

26 September 2024 13:00-18:00


Introduction
The program features case studies in vaccine development for cancer and infectious diseases, offering insights into best practices and technological advancements. Engage in focused discussions and networking with thought leaders to understand immunotherapy innovations for cancer and autoimmune diseases. The event concludes with the release of the ‘Harnessing Vaccine Technologies & Immunotherapies with Best Practice Approaches’ report, summarizing key insights and emerging trends.

Vaccines & Immunotherapies Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Confirmed speakers include: Amita Vaidya, Principal Scientist from Sanofi, Brian Schanen, Global Head of Biomarkers at Sanofi, Mabrouka Maamra, Project Manager at University of Sheffield, Mats Lundgren, CSO at Abera Bioscience, Samantha Paston, Head of translational research at Scancell ltd, and Tobias von der Haar, Professor of Systems Biology at University of Kent.

Useful links

Speakers
  • Amita Vaidya Principal Scientist from Sanofi, United States
  • Brian Schanen Global Head of Biomarkers at Sanofi, United States
  • Mabrouka Maamra Project Manager at University of Sheffield, United Kingdom
  • Mats Lundgren CSO at Abera Bioscience, Sweden
  • Samantha Paston Head of translational research at Scancell ltd, United Kingdom
  • Tobias von der Haar Professor of Systems Biology at University of Kent, United Kingdom

Organised by

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*